BRIEF published on 10/08/2024 at 08:05, 1 month 13 days ago Eckert & Ziegler et GlyTherix signent un accord de fourniture de lutétium-177 Essais Cliniques Traitement Du Cancer Produits Radiopharmaceutiques Lutetium-177 Partenariat GlyTherix
PRESS RELEASE published on 10/08/2024 at 08:00, 1 month 13 days ago Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply Eckert & Ziegler and GlyTherix sign global agreement for Lutetium-177 supply, aiming for innovative cancer treatments with targeted radiotherapy Clinical Trials Eckert & Ziegler Lutetium-177 GlyTherix Radiotherapy
BRIEF published on 10/02/2024 at 11:48, 1 month 19 days ago Eckert & Ziegler : enregistrement de la scission de Pentixapharm AG Bourse De Francfort Spin Off Répartition Des Actions Registre Du Commerce Pentixapharm AG
BRIEF published on 10/02/2024 at 11:48, 1 month 19 days ago Eckert & Ziegler: Spin-off of Pentixapharm AG Registered Frankfurt Stock Exchange Spin-off Commercial Register Pentixapharm AG Share Allocation
PRESS RELEASE published on 10/02/2024 at 11:43, 1 month 19 days ago Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register Eckert & Ziegler SE successfully completes the spin-off of Pentixapharm AG, transferring shares to Pentixapharm Holding AG as per the approved resolution at the Annual General Meeting Shareholders Spin-off Commercial Register Eckert & Ziegler SE Pentixapharm AG
BRIEF published on 08/20/2024 at 17:05, 3 months 1 day ago Eckert & Ziegler ouvre de nouvelles installations radiopharmaceutiques à Dresde Investissement Expansion Emploi Produits Radiopharmaceutiques Dresde
BRIEF published on 08/20/2024 at 17:05, 3 months 1 day ago Eckert & Ziegler Opens New Radiopharmaceutical Facilities in Dresden Expansion Investment Radiopharmaceuticals Employment Dresden
PRESS RELEASE published on 08/20/2024 at 17:00, 3 months 1 day ago Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden Eckert & Ziegler inaugurates new radiopharmaceutical plant engineering facilities in Dresden, investing up to €50 million for further expansion and job creation Expansion Eckert & Ziegler Inauguration Radiopharmaceuticals Dresden
BRIEF published on 08/13/2024 at 09:05, 3 months 8 days ago Eckert & Ziegler devient fabricant sous contrat européen pour l'étude de phase III ProstACT GLOBAL de Telix Étude Clinique Produits Radiopharmaceutiques Fabrication Sous Contrat Lu-177 Cancer De La Prostate
BRIEF published on 08/13/2024 at 09:05, 3 months 8 days ago Eckert & Ziegler Becomes European Contract Manufacturer for Telix's Phase III ProstACT GLOBAL Study Clinical Study Radiopharmaceuticals Contract Manufacturing Prostate Cancer Lu-177
Published on 11/21/2024 at 17:35, 44 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 49 minutes ago SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 49 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 18 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 19 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 17:51, 27 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 27 minutes ago LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 27 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 17:51, 27 minutes ago 2CRSi SA: 2CRSi fournit à Exaion, filiale du groupe EDF, des serveurs à hautes performances en immersion en Amérique du Nord
Published on 11/21/2024 at 06:58, 11 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 11 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 11 hours 21 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 22 hours 11 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 22 hours 58 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
